GLUT1 gene polymorphism in non-insulin-dependent diabetes mellitus: Genetic susceptibility relationship with cardiovascular risk factors and microangiopathic complications in a Mediterranean population

Diabetes Research and Clinical Practice

Volumn 41, Issue 2, 1998, Pages 113-120

  Gutierrez, C ^a   Vendrell, J ^a   Pastor, R ^a   Broch, M ^a   Aguilar, C ^a   Llor, C ^a   Simon, I ^a   Richart, C ^a  

^a Research Unit   (Spain)

Author keywords

Cardiovascular risk factors; GLUT1 glucose transporter; Hypertension; Nephropathy; Retinopathy; Type 2 diabetes

Indexed keywords

DNA; GLUCOSE TRANSPORTER;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; MALE; MEDITERRANEAN SEA; MICROCIRCULATION; MIDDLE AGED; MONOSACCHARIDE TRANSPORT PROTEINS; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; SEX CHARACTERISTICS;

EID: 0032143644     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(98)00050-3     Document Type: Article

References (21)

1. Zorzano A., Wilkinson W., Kotliar N.et al. Insulin-regulated glucose uptake in rat adipocytes is mediated by two transporter isoforms present in at least two vesicle populations. J. Biol. Chem. 264:1989;12358-12363.
2. Mueckler M., Caruso C., Baldwin S.et al. Sequence and structure of a human glucose transporter. Science. 229:1985;225-248.
3. Gould G.W., Derechin V., James D.E.et al. Insulin-stimulated translocation of the HepG2/erythrocyte-type glucose transporter expressed in 3T3-L1 adipocytes. J. Biol. Chem. 264:1989;4758-4762.
4. DeFronzo R.A. The triumvirate: B-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes. 37:1988;667-687.
5. Li S.R., Baroni M.G., Oelbaum R.S., Stocks J., Galton D.J. Association of genetic variant of the glucose transporter with non-insulin-dependent diabetes mellitus. Lancet. II:1988;368-370.
6. Baroni M.G., Oelbaum R.S., Pozzilli P.et al. Polymorphisms at the GLUT1 (HepG2) and GLUT4 (muscle/adipocyte) glucose transporter genes and non-insulin-dependent diabetes mellitus (NIDDM). Hum. Genet. 88:1992;557-561.
7. Tao T., Tanizawa Y., Matsutani A., Matsubara A., Kaneko T., Kaku K. HepG2/erythrocyte glucose transporter (GLUT1) gene in NIDDM: a population association study and molecular scanning in Japanese subjects. Diabetologia. 38:1995;942-947.
8. Cox N.J., Xiang K.S., Bell G.I., Karam J.H. Glucose transporter gene and non-insulin-dependent diabetes. Lancet. II:1988;793-794.
9. Cox N.J., Bell G.I. Disease associations. Chance, artifact or susceptibility genes? Diabetes. 38:1989;947-950.
10. Li S.R., Oelbaum R.S., Bouloux P.M.G., Stocks J., Baroni M.G., Galton D.J. Restriction site polymorphisms at the human HepG2 glucose transporter gene locus in Caucasians and Italian subjects with non-insulin-dependent diabetes mellitus. Hum. Hered. 40:1990;38-44.
11. Kaku K., Matsutani A., Mueckler M., Permutt M.A. Polymorphisms of the HepG2/erythrocyte glucose-transporter gene. Diabetes. 39:1990;49-56.
12. Alcolado J.C., Baroni M.G. Restriction fragment length polymorphisms at the GLUT4 and GLUT1 gene loci in type 2 diabetes. Diabet. Med. 9:1992;58-60.
13. Oelbaum R.S. Analysis of three glucose transporter genes in a Caucasian population: no association with non-insulin-dependent diabetes and obesity. Clin. Genet. 42:1992;260-266.
14. Magnani C., Capra F., Calderara A.et al. Type 2 (non-insulin-dependent) diabetes mellitus and glucose transporter gene (GLUT1 and GLUT4) polymorphism. Acta Diabetol. 29:1992;110-112.
15. Pontiroli A.E., Capra F., Veglia F.et al. Genetic contribution of polymorphism of the GLUT1 and GLUT4 genes to the susceptibility to type 2 (non-insulin-dependent) diabetes mellitus in different populations. Acta Diabetol. 33:1996;193-197.
16. Kannel W.B., McGee D.L. Diabetes and cardiovascular risk factors: the Framingham study. Circulation. 59:1979;8-13.
17. Heilig C.W., Concepcion L.A., Riser B.L., Freytag S.O., Zhu M., Cortes P. Overexpression of glucose transporters in rat mesangial cell cultures in a normal glucose milieu mimics the diabetic phenotype. J. Clin. Invest. 96:1995;1802-1814.
18. Muls E., Blaton V., Rosseneu M. Serum lipids and apolipoprotein A1, A2 and B in hyperthyroidism before and after treatment. J. Clin. Endocrinol. Metab. 55:1982;459-464.
19. Lipids Research Clinics, Manual of Laboratory Operations, Lipids Research Clinics Program, Vol. 1, Lipid and Lipoprotein Analysis, DHEW publ. no. NIH 75-628, US Government Printing Office, Washington DC, 1984.
20. Simonson D.C. Etiology and prevalence of hypertension in diabetic patients. Diabetes Care. 11:1988;821-827.
21. Mogensen C.E. Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. New Engl. J. Med. 310:1984;356-360.